Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Neurosteroids show promise for treating epilepsy and more research is needed.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Finasteride helps reduce heart issues and improves heart function.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

New treatments aim to improve thin endometrium to help more couples with infertility.

Androgens may block hair growth signals, targeting this could treat hair loss.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Left-handed men experience more sexual side effects from finasteride treatment.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.